Altimmune to Host Key Opinion Leader Call with Dr. Stephen Harrison on Pemvidutide Phase 1 Clinical Trial Results on September 30, 2021
GAITHERSBURG, Md., Sept. 29, 2021 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical…
SonicStrategy Acquires Additional SYN Tokens and Announces Grant of Stock Options
Universal Digital Inc. Announces Second Amendment to Helena Promissory Note
Planet Ventures Inc. Announces Resignation of Chief Executive Officer
NamSys Reports Third Quarter Results
Tantalus Systems Added to Nasdaq OMX Clean Edge Smart Grid Infrastructure Index and First Trust Smart Grid Infrastructure ETF (GRID)